SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-12-119648
Filing Date
2012-03-16
Accepted
2012-03-16 16:05:27
Documents
6
Period of Report
2011-12-28
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K AMENDMENT d315516d8ka.htm 8-K/A 18935
2 CONSENT OF ERNST & YOUNG LLP d315516dex231.htm EX-23.1 2658
3 AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF CARDIOKINE, INC. FOR 2008 AND 2009 d315516dex991.htm EX-99.1 341810
4 AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF CARDIOKINE, INC. FOR 2009 AND 2010 d315516dex992.htm EX-99.2 339689
5 UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS OF CARDIOKINE, INC. d315516dex993.htm EX-99.3 275420
6 UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS OF THE COMPANY d315516dex994.htm EX-99.4 189404
  Complete submission text file 0001193125-12-119648.txt   1169100
Mailing Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518 919-678-6611
CORNERSTONE THERAPEUTICS INC (Filer) CIK: 0001145404 (see all company filings)

IRS No.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-50767 | Film No.: 12697726
SIC: 2834 Pharmaceutical Preparations